Market revenue in 2024 | USD 10.3 million |
Market revenue in 2030 | USD 15.2 million |
Growth rate | 6.6% (CAGR from 2025 to 2030) |
Largest segment | Leukapheresis devices |
Fastest growing segment | Leukapheresis Disposables |
Historical data covered | 2018 - 2023 |
Base year for estimation | 2024 |
Forecast period covered | 2025 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Leukapheresis Devices, Leukapheresis Disposables |
Key market players worldwide | Charles River Laboratories International Inc, Adacyte Therapeutics, AllCells, Haemonetics Corp, Macopharma, Cerus Corp, Kawasumi Laboratories, StemExpress, Lonza Group Ltd, Asahi Kasei Corp |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to leukapheresis market will help companies and investors design strategic landscapes.
Leukapheresis devices was the largest segment with a revenue share of 73.79% in 2024. Horizon Databook has segmented the Middle East & Africa leukapheresis market based on leukapheresis devices, leukapheresis disposables covering the revenue growth of each sub-segment from 2018 to 2030.
Horizon Databook provides a detailed overview of continent-level data and insights on the Middle East & Africa leukapheresis market , including forecasts for subscribers. This continent databook contains high-level insights into Middle East & Africa leukapheresis market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account